1Venook AP. Papandreou C. FuruseJ. et al, The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist. 2010. 15 SuppI4:5-13.
2Ercolani G. Grazi GL, Ravaioli M. et aL Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann Surg , 2003. 237(4):536-543.
3Olthoff KM. Rosove MH. Shackleton CR. et al. Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma. Ann Surg , 1995. 221 (6): 734-743.
4Mazzaferro V. Regalia E. Doci R. et aL Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N EnglJ Med. 1996. 334 (11) : 693-699.
5Yao FY. Ferrell L. Bass NM. et aL Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survivaL Hepatology , 2001. 33(6): 1394-1403.
6Zheng SS. Xu X. WuJ. et aL Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation. 2008. 85 (12) : 1726-1732.
7Adam R. Azoulay D. Castaing D. et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg , 2003. 238 (4) : 508-519.
8S derdahl G. B ckman L. Isoniemi H. et aL A prospective. randomized. multi-centre trial of systemic adjuvant chemotherapy versus no additional treatment in liver transplantation for hepatocellular carcinoma. Transpl Int. 2006. 19(4) :288-294.
9Fisher RA. Kulik LM. Freise CEo et aL Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. AmJ Transplant. 2007. 7 (6) : 160H608.
10Liang W. Wu L. Ling X. et aL Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis. Liver T ranspl , 2012. 18(10): 1226-1236.
